awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38795712-1B8ED5FC-4D33-4EA6-8AF5-553F7A010F83
Q38795712-1B8ED5FC-4D33-4EA6-8AF5-553F7A010F83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38795712-1B8ED5FC-4D33-4EA6-8AF5-553F7A010F83
PARP inhibitors as antitumor agents: a patent update (2013-2015).
P2860
Q38795712-1B8ED5FC-4D33-4EA6-8AF5-553F7A010F83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38795712-1B8ED5FC-4D33-4EA6-8AF5-553F7A010F83
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d595f71da5d2e047a49d1a5a8dd6e6a0596524f
P2860
A phase II evaluation of the potent, highly selective PARP inhibitor veliparib in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in patients who carry a germline BRCA1 or BRCA2 mutation - An